table of content
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Cholera Vaccines
1.2 Key Market Segments
1.2.1 Cholera Vaccines Segment by Type
1.2.2 Cholera Vaccines Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Cholera Vaccines Market Overview
2.1 Global Market Overview
2.1.1 Global Cholera Vaccines Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Cholera Vaccines Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Cholera Vaccines Market Competitive Landscape
3.1 Global Cholera Vaccines Sales by Manufacturers (2019-2024)
3.2 Global Cholera Vaccines Revenue Market Share by Manufacturers (2019-2024)
3.3 Cholera Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Cholera Vaccines Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Cholera Vaccines Sales Sites, Area Served, Product Type
3.6 Cholera Vaccines Market Competitive Situation and Trends
3.6.1 Cholera Vaccines Market Concentration Rate
3.6.2 Global 5 and 10 Largest Cholera Vaccines Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Cholera Vaccines Industry Chain Analysis
4.1 Cholera Vaccines Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Cholera Vaccines Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Cholera Vaccines Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Cholera Vaccines Sales Market Share by Type (2019-2024)
6.3 Global Cholera Vaccines Market Size Market Share by Type (2019-2024)
6.4 Global Cholera Vaccines Price by Type (2019-2024)
7 Cholera Vaccines Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Cholera Vaccines Market Sales by Application (2019-2024)
7.3 Global Cholera Vaccines Market Size (M USD) by Application (2019-2024)
7.4 Global Cholera Vaccines Sales Growth Rate by Application (2019-2024)
8 Cholera Vaccines Market Segmentation by Region
8.1 Global Cholera Vaccines Sales by Region
8.1.1 Global Cholera Vaccines Sales by Region
8.1.2 Global Cholera Vaccines Sales Market Share by Region
8.2 North America
8.2.1 North America Cholera Vaccines Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Cholera Vaccines Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Cholera Vaccines Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Cholera Vaccines Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Cholera Vaccines Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Shantha Biotechnics Private Limited
9.1.1 Shantha Biotechnics Private Limited Cholera Vaccines Basic Information
9.1.2 Shantha Biotechnics Private Limited Cholera Vaccines Product Overview
9.1.3 Shantha Biotechnics Private Limited Cholera Vaccines Product Market Performance
9.1.4 Shantha Biotechnics Private Limited Business Overview
9.1.5 Shantha Biotechnics Private Limited Cholera Vaccines SWOT Analysis
9.1.6 Shantha Biotechnics Private Limited Recent Developments
9.2 PaxVax, Inc.
9.2.1 PaxVax, Inc. Cholera Vaccines Basic Information
9.2.2 PaxVax, Inc. Cholera Vaccines Product Overview
9.2.3 PaxVax, Inc. Cholera Vaccines Product Market Performance
9.2.4 PaxVax, Inc. Business Overview
9.2.5 PaxVax, Inc. Cholera Vaccines SWOT Analysis
9.2.6 PaxVax, Inc. Recent Developments
9.3 Valneva SE
9.3.1 Valneva SE Cholera Vaccines Basic Information
9.3.2 Valneva SE Cholera Vaccines Product Overview
9.3.3 Valneva SE Cholera Vaccines Product Market Performance
9.3.4 Valneva SE Cholera Vaccines SWOT Analysis
9.3.5 Valneva SE Business Overview
9.3.6 Valneva SE Recent Developments
9.4 Merck and Co., Inc.
9.4.1 Merck and Co., Inc. Cholera Vaccines Basic Information
9.4.2 Merck and Co., Inc. Cholera Vaccines Product Overview
9.4.3 Merck and Co., Inc. Cholera Vaccines Product Market Performance
9.4.4 Merck and Co., Inc. Business Overview
9.4.5 Merck and Co., Inc. Recent Developments
9.5 GlaxoSmithKline plc (GSK)
9.5.1 GlaxoSmithKline plc (GSK) Cholera Vaccines Basic Information
9.5.2 GlaxoSmithKline plc (GSK) Cholera Vaccines Product Overview
9.5.3 GlaxoSmithKline plc (GSK) Cholera Vaccines Product Market Performance
9.5.4 GlaxoSmithKline plc (GSK) Business Overview
9.5.5 GlaxoSmithKline plc (GSK) Recent Developments
9.6 Astellas Pharma, Inc.
9.6.1 Astellas Pharma, Inc. Cholera Vaccines Basic Information
9.6.2 Astellas Pharma, Inc. Cholera Vaccines Product Overview
9.6.3 Astellas Pharma, Inc. Cholera Vaccines Product Market Performance
9.6.4 Astellas Pharma, Inc. Business Overview
9.6.5 Astellas Pharma, Inc. Recent Developments
9.7 Pfizer, Inc.
9.7.1 Pfizer, Inc. Cholera Vaccines Basic Information
9.7.2 Pfizer, Inc. Cholera Vaccines Product Overview
9.7.3 Pfizer, Inc. Cholera Vaccines Product Market Performance
9.7.4 Pfizer, Inc. Business Overview
9.7.5 Pfizer, Inc. Recent Developments
9.8 Emergent BioSolutions, Inc.
9.8.1 Emergent BioSolutions, Inc. Cholera Vaccines Basic Information
9.8.2 Emergent BioSolutions, Inc. Cholera Vaccines Product Overview
9.8.3 Emergent BioSolutions, Inc. Cholera Vaccines Product Market Performance
9.8.4 Emergent BioSolutions, Inc. Business Overview
9.8.5 Emergent BioSolutions, Inc. Recent Developments
9.9 Mitsubishi Tanabe Pharma Corporation
9.9.1 Mitsubishi Tanabe Pharma Corporation Cholera Vaccines Basic Information
9.9.2 Mitsubishi Tanabe Pharma Corporation Cholera Vaccines Product Overview
9.9.3 Mitsubishi Tanabe Pharma Corporation Cholera Vaccines Product Market Performance
9.9.4 Mitsubishi Tanabe Pharma Corporation Business Overview
9.9.5 Mitsubishi Tanabe Pharma Corporation Recent Developments
9.10 Takeda Pharmaceutical Co., Ltd.
9.10.1 Takeda Pharmaceutical Co., Ltd. Cholera Vaccines Basic Information
9.10.2 Takeda Pharmaceutical Co., Ltd. Cholera Vaccines Product Overview
9.10.3 Takeda Pharmaceutical Co., Ltd. Cholera Vaccines Product Market Performance
9.10.4 Takeda Pharmaceutical Co., Ltd. Business Overview
9.10.5 Takeda Pharmaceutical Co., Ltd. Recent Developments
10 Cholera Vaccines Market Forecast by Region
10.1 Global Cholera Vaccines Market Size Forecast
10.2 Global Cholera Vaccines Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Cholera Vaccines Market Size Forecast by Country
10.2.3 Asia Pacific Cholera Vaccines Market Size Forecast by Region
10.2.4 South America Cholera Vaccines Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Cholera Vaccines by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Cholera Vaccines Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Cholera Vaccines by Type (2025-2030)
11.1.2 Global Cholera Vaccines Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Cholera Vaccines by Type (2025-2030)
11.2 Global Cholera Vaccines Market Forecast by Application (2025-2030)
11.2.1 Global Cholera Vaccines Sales (K Units) Forecast by Application
11.2.2 Global Cholera Vaccines Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
